Published in Gut Liver on November 15, 2014
Cytomegalovirus and ulcerative colitis: Place of antiviral therapy. World J Gastroenterol (2016) 0.93
A clinical significance of assessing cytomegalovirus infection status in patients with ulcerative colitis. Intest Res (2015) 0.83
The cumulative colectomy rate in patients with cytomegalovirus-positive ulcerative colitis. Gut Liver (2015) 0.83
Second Korean guidelines for the management of ulcerative colitis. Intest Res (2017) 0.83
Cytomegalovirus in inflammatory bowel disease: A systematic review. World J Gastroenterol (2016) 0.81
Cytomegalovirus colitis in hospitalized inflammatory bowel disease patients in Taiwan: a referral center study. BMC Gastroenterol (2017) 0.75
Approach to cytomegalovirus infections in patients with ulcerative colitis. Korean J Intern Med (2017) 0.75
Author's Reply. Intest Res (2015) 0.75
Preoperative Corticosteroid Usage and Hypoalbuminemia Increase Occurrence of Short-term Postoperative Complications in Chinese Patients with Ulcerative Colitis. Chin Med J (Engl) (2016) 0.75
Reply: careful assessment is needed in patients with ulcerative colitis with evidence of cytomegalovirus reactivation. Gut Liver (2015) 0.75
Gastrointestinal cytomegalovirus disease. Ann Intern Med (1993) 4.35
European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis (2009) 3.22
Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis. Am J Gastroenterol (2001) 2.93
The prevalence and efficacy of ganciclovir on steroid-refractory ulcerative colitis with cytomegalovirus infection: a prospective multicenter study. J Clin Gastroenterol (2012) 2.53
Cytomegalovirus infection in ulcerative colitis: a prospective, comparative study on prevalence and diagnostic strategy. Inflamm Bowel Dis (2008) 2.17
Frequent detection of cytomegalovirus in the intestine of patients with inflammatory bowel disease. Inflamm Bowel Dis (2006) 1.98
Severe acute colitis associated with CMV: a prevalence study. Dig Liver Dis (2004) 1.82
Interferon-gamma and tumor necrosis factor-alpha specifically induce formation of cytomegalovirus-permissive monocyte-derived macrophages that are refractory to the antiviral activity of these cytokines. J Clin Invest (1997) 1.62
Cytomegalovirus Reactivation in Ulcerative Colitis Patients. Ulcers (2011) 1.34
Cytomegalovirus colitis complicating ulcerative colitis in the steroid-naive patient. Am J Gastroenterol (2001) 1.34
Summary of the II International Symposium on Cytomegalovirus. Antiviral Res (1998) 1.21
Cytomegalovirus complicating inflammatory bowel disease: a 10-year experience in a community-based, university-affiliated hospital. Gastroenterol Hepatol (N Y) (2012) 1.20
Intractable ulcerative colitis caused by cytomegalovirus infection: a prospective study on prevalence, diagnosis, and treatment. Dis Colon Rectum (2003) 1.14
The prevalence and risk factors of cytomegalovirus infection in inflammatory bowel disease in Wuhan, Central China. Virol J (2013) 1.06
Cytomegalovirus infection in patients with new onset ulcerative colitis: a prospective study. Hepatogastroenterology (2012) 1.05
Severe disease activity and cytomegalovirus colitis are predictive of a nonresponse to infliximab in patients with ulcerative colitis. Dig Dis Sci (2013) 1.03
Diagnosis and treatment of ulcerative colitis with cytomegalovirus infection: importance of controlling mucosal inflammation to prevent cytomegalovirus reactivation. Intest Res (2014) 1.03
The role of CMV in steroid-resistant ulcerative colitis: A systematic review. J Crohns Colitis (2009) 1.00
Human cytomegalovirus persists in its host and attacks and avoids elimination by the immune system. Crit Rev Immunol (2006) 0.94
Toxic megacolon associated with cytomegalovirus infection in a patient with steroid-naïve ulcerative colitis. Intern Med (2012) 0.85